APO Research
Talk to an analyst

APO RESEARCH · REPORT

PNH and aHUS

PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.

Selected research

Market Outlook & Growth Opportunities

Global PNH and aHUS Market Outlook and Growth Opportunities 2026

30 December 2025190 pages

Choose your research edition.

Industry ResearchPNH and aHUS Industry Research Report 2026103 pages · $2,950 USDIndustry Growth & TrendsGlobal PNH and aHUS Industry Growth and Trends Forecast to 203261 pages · $3,450 USDMarket StructureGlobal PNH and aHUS Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PNH and aHUS Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal PNH and aHUS Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.

United States is the largest consumption place, with a consumption market share nearly 52.1% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 26.2%.

This report provides an overview of the global PNH and aHUS market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of PNH and aHUS and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents PNH and aHUS revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global PNH and aHUS market.

PNH and aHUS Segment by Company

Alexion Pharmaceuticals

Alnylam Pharmaceuticals

Omeros Corporation

PNH and aHUS Segment by Type

Soliris

Ultomiris

PNH and aHUS Segment by Application

PNH

aHUS

PNH and aHUS Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global PNH and aHUS status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the PNH and aHUS key companies, revenue, market share, and recent developments.

3. To split the PNH and aHUS breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions PNH and aHUS market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify PNH and aHUS significant trends, drivers, influence factors in global and regions.

6. To analyze PNH and aHUS competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PNH and aHUS market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PNH and aHUS and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PNH and aHUS.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global PNH and aHUS industry.

Chapter 3: Detailed analysis of PNH and aHUS company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of PNH and aHUS in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of PNH and aHUS in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. PNH and aHUS Industry Trends Table 2. PNH and aHUS Industry Drivers Table 3. PNH and aHUS Industry Opportunities and Challenges Table 4. PNH and aHUS Industry Restraints Table 5. Global PNH and aHUS Revenue by Company (US$ Million) & (2021-2026) Table 6. Global PNH and aHUS Revenue Share by Company (2021-2026) Table 7. Global PNH and aHUS Company Ranking, (2024-2026) & (US$ Million) Table 8. Global PNH and aHUS Key Company Manufacturing Base & Headquarters Table 9. Global PNH and aHUS Company, Product Type & Application Table 10. Global PNH and aHUS Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global PNH and aHUS by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Soliris Table 15. Significant Companies of Ultomiris Table 16. Global PNH and aHUS Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global PNH and aHUS Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global PNH and aHUS Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global PNH and aHUS Sales Value Share by Type (2021-2026) Table 20. Global PNH and aHUS Sales Value Share by Type (2027-2032) Table 21. Significant Companies of PNH Table 22. Significant Companies of aHUS Table 23. Global PNH and aHUS Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global PNH and aHUS Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global PNH and aHUS Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global PNH and aHUS Sales Value Share by Application (2021-2026) Table 27. Global PNH and aHUS Sales Value Share by Application (2027-2032) Table 28. Global PNH and aHUS Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global PNH and aHUS Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global PNH and aHUS Sales Value Share by Region (2021-2026) Table 31. Global PNH and aHUS Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global PNH and aHUS Sales Value Share by Region (2027-2032) Table 33. Global PNH and aHUS Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global PNH and aHUS Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global PNH and aHUS Sales Value Market Share by Country (2021-2026) Table 36. Global PNH and aHUS Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global PNH and aHUS Sales Value Market Share by Country (2027-2032) Table 38. Alexion Pharmaceuticals Company Information Table 39. Alexion Pharmaceuticals Business Overview Table 40. Alexion Pharmaceuticals PNH and aHUS Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Alexion Pharmaceuticals PNH and aHUS Product Portfolio Table 42. Alexion Pharmaceuticals Recent Development Table 43. Alnylam Pharmaceuticals Company Information Table 44. Alnylam Pharmaceuticals Business Overview Table 45. Alnylam Pharmaceuticals PNH and aHUS Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Alnylam Pharmaceuticals PNH and aHUS Product Portfolio Table 47. Alnylam Pharmaceuticals Recent Development Table 48. Omeros Corporation Company Information Table 49. Omeros Corporation Business Overview Table 50. Omeros Corporation PNH and aHUS Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Omeros Corporation PNH and aHUS Product Portfolio Table 52. Omeros Corporation Recent Development Table 53. Research Programs/Design for This Report Table 54. Authors List of This Report Table 55. Secondary Sources Table 56. Primary Sources List of Figures Figure 1. PNH and aHUS Product Image Figure 2. Global PNH and aHUS Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PNH and aHUS Market Size (2021-2032) & (US$ Million) Figure 4. Global PNH and aHUS Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Soliris Image Figure 8. Ultomiris Image Figure 9. Global PNH and aHUS Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global PNH and aHUS Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global PNH and aHUS Sales Value Share by Type (2021-2032) Figure 12. PNH Image Figure 13. aHUS Image Figure 14. Global PNH and aHUS Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global PNH and aHUS Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global PNH and aHUS Sales Value Share by Application (2021-2032) Figure 17. Global PNH and aHUS Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global PNH and aHUS Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America PNH and aHUS Sales Value (2021-2032) & (US$ Million) Figure 20. North America PNH and aHUS Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe PNH and aHUS Sales Value (2021-2032) & (US$ Million) Figure 22. Europe PNH and aHUS Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific PNH and aHUS Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific PNH and aHUS Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America PNH and aHUS Sales Value (2021-2032) & (US$ Million) Figure 26. South America PNH and aHUS Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa PNH and aHUS Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa PNH and aHUS Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt PNH and aHUS Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt PNH and aHUS Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt PNH and aHUS Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Soliris
  • Ultomiris
Applications
  • PNH
  • aHUS
Companies covered
  • Alexion Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Omeros Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global PNH and aHUS Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global PNH and aHUS Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 PNH and aHUS Market Dynamics
  1. 2.1 PNH and aHUS Industry Trends
  2. 2.2 PNH and aHUS Industry Drivers
  3. 2.3 PNH and aHUS Industry Opportunities and Challenges
  4. 2.4 PNH and aHUS Industry Restraints
3 PNH and aHUS Market by Company
  1. 3.1 Global PNH and aHUS Company Revenue Ranking in 2025
  2. 3.2 Global PNH and aHUS Revenue by Company (2021-2026)
  3. 3.3 Global PNH and aHUS Company Ranking (2024-2026)
  4. 3.4 Global PNH and aHUS Company Manufacturing Base and Headquarters
  5. 3.5 Global PNH and aHUS Company Product Type and Application
  6. 3.6 Global PNH and aHUS Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global PNH and aHUS Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 PNH and aHUS Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 PNH and aHUS Market by Type
  1. 4.1 PNH and aHUS Type Introduction
  2. 4.1.1 Soliris
  3. 4.1.2 Ultomiris
  4. 4.2 Global PNH and aHUS Sales Value by Type
  5. 4.2.1 Global PNH and aHUS Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global PNH and aHUS Sales Value by Type (2021-2032)
  7. 4.2.3 Global PNH and aHUS Sales Value Share by Type (2021-2032)
5 PNH and aHUS Market by Application
  1. 5.1 PNH and aHUS Application Introduction
  2. 5.1.1 PNH
  3. 5.1.2 aHUS
  4. 5.2 Global PNH and aHUS Sales Value by Application
  5. 5.2.1 Global PNH and aHUS Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global PNH and aHUS Sales Value by Application (2021-2032)
  7. 5.2.3 Global PNH and aHUS Sales Value Share by Application (2021-2032)
6 PNH and aHUS Regional Value Analysis
  1. 6.1 Global PNH and aHUS Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global PNH and aHUS Sales Value by Region (2021-2032)
  3. 6.2.1 Global PNH and aHUS Sales Value by Region: 2021-2026
  4. 6.2.2 Global PNH and aHUS Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America PNH and aHUS Sales Value (2021-2032)
  7. 6.3.2 North America PNH and aHUS Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe PNH and aHUS Sales Value (2021-2032)
  10. 6.4.2 Europe PNH and aHUS Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific PNH and aHUS Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific PNH and aHUS Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America PNH and aHUS Sales Value (2021-2032)
  16. 6.6.2 South America PNH and aHUS Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa PNH and aHUS Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa PNH and aHUS Sales Value Share by Country, 2025 VS 2032
7 PNH and aHUS Country-level Value Analysis
  1. 7.1 Global PNH and aHUS Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global PNH and aHUS Sales Value by Country (2021-2032)
  3. 7.2.1 Global PNH and aHUS Sales Value by Country (2021-2026)
  4. 7.2.2 Global PNH and aHUS Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA PNH and aHUS Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada PNH and aHUS Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico PNH and aHUS Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany PNH and aHUS Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France PNH and aHUS Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. PNH and aHUS Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy PNH and aHUS Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain PNH and aHUS Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia PNH and aHUS Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands PNH and aHUS Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries PNH and aHUS Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China PNH and aHUS Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan PNH and aHUS Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea PNH and aHUS Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India PNH and aHUS Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia PNH and aHUS Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia PNH and aHUS Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil PNH and aHUS Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina PNH and aHUS Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile PNH and aHUS Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia PNH and aHUS Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru PNH and aHUS Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia PNH and aHUS Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel PNH and aHUS Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE PNH and aHUS Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey PNH and aHUS Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran PNH and aHUS Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran PNH and aHUS Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt PNH and aHUS Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt PNH and aHUS Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt PNH and aHUS Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alexion Pharmaceuticals
  2. 8.1.1 Alexion Pharmaceuticals Company Information
  3. 8.1.2 Alexion Pharmaceuticals Business Overview
  4. 8.1.3 Alexion Pharmaceuticals PNH and aHUS Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alexion Pharmaceuticals PNH and aHUS Product Portfolio
  6. 8.1.5 Alexion Pharmaceuticals Recent Developments
  7. 8.2 Alnylam Pharmaceuticals
  8. 8.2.1 Alnylam Pharmaceuticals Company Information
  9. 8.2.2 Alnylam Pharmaceuticals Business Overview
  10. 8.2.3 Alnylam Pharmaceuticals PNH and aHUS Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Alnylam Pharmaceuticals PNH and aHUS Product Portfolio
  12. 8.2.5 Alnylam Pharmaceuticals Recent Developments
  13. 8.3 Omeros Corporation
  14. 8.3.1 Omeros Corporation Company Information
  15. 8.3.2 Omeros Corporation Business Overview
  16. 8.3.3 Omeros Corporation PNH and aHUS Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Omeros Corporation PNH and aHUS Product Portfolio
  18. 8.3.5 Omeros Corporation Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst